Delivery Order SPE2DB22D2007-SPE2DB24FH9NN

Award Date 2/12/24
Potential Completion Date 2/13/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $1,973.76 contract is for the supply of HYZAAR 50-12.5 TABLET 30S, a pharmaceutical product, to be delivered by January 30, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 through...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,783.97 firm fixed-price delivery order is for the supply of HYZAAR 100-25 tablets, with a period of performance through January 17, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,415.58, is a Delivery Order for the procurement of HYZAAR 100-25 Tablets with an ultimate completion date of May 23, 2024. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of HYZAAR 50-12.5 tablets. The order has a completion date of January 31, 2024 and a potential value of $1,294.97. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued at up...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,881.84, is a Delivery Order for the supply of HYZAAR 100-12.5 TABLET 30S medical products. The contract has a firm fixed price and an ultimate completion date of February 7, 2024. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award, with ID SPE2DB20D1100|SPE2DB24FC4F1, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,270.92 firm fixed-price delivery order covers the supply of HYZAAR 50-12.5 TABLET 30S, a pharmaceutical product, with a performance period through June 26, 2024. This contract award is not designated as a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award is for the delivery of HYZAAR 100-12.5 TABLET 30S medication, awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $9,635.71 firm fixed-price delivery order contract has a completion date of November 21, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within military and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price delivery order with a ceiling value of $1,926.20 and an ultimate completion date of June 5, 2025. The contract provides for the delivery of HYZAAR 50-12.5 TABLET 30S, a pharmaceutical product, to support federal healthcare requirements. Amerisourcebergen Drug Corp holds a larger...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a large pharmaceutical distribution company. The $2,275.00 firm-fixed price delivery order is for the supply of HYZAAR 100-25 Tablets (30 count) to support DLA's medical supply requirements. The award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical. This single-award IDC serves as the main...
This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply HYZAAR 50-12.5 TABLET 30S pharmaceuticals. The contract has a potential value of $1,973.76 and a completion date of January 9, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, has received numerous federal contracts to provide pharmaceutical products and medical supplies to support DLA Troop...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB24FH9NN
    Delivery Order

This federal contract award is a firm fixed price delivery order between the Defense Logistics Agency (DLA) and Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The award is for the supply of HYZAAR 50-12.5 TABLET 30S, a pharmaceutical product, with a potential value of $1,102.08 and a completion date of February 13, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp serves as the prime contractor on this delivery order, which is likely part of a larger indefinite delivery contract (IDC) the company holds with DLA to provide a comprehensive range of pharmaceutical products and medical supplies to Department of Defense military treatment programs and facilities worldwide. The IDC has a potential value of $999,999,999.00 and a performance period through December 31, 2025, making it a significant contract vehicle for Amerisourcebergen to support the healthcare needs of the U.S. military.

Generated 5/13/24, 9:25 AM